Establishment of a Database of Thromboelastography (TEG) in Liver Transplantation Surgery

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2500099696

Enrollment

Unknown

Registered

2025-03-27

Start date

2025-04-01

Completion date

Unknown

Last updated

2025-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

he coagulation status of liver transplant patients during the operation

Interventions

Observation group (receiving planned liver transplantation surgery):nono

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.The organ transplant patients in our hospital who are scheduled to undergo liver transplantation under general anesthesia.

Exclusion criteria

Exclusion criteria: 1.Cardiac arrest during surgery; 2.Death within 24 hours after the operation;

Design outcomes

Primary

Measure	Time frame
results of TEG (R value, K value, alpha angle MALY30 Solidification time and blood clot strength;	—

Secondary

Measure	Time frame
Intraoperative transfusion volume of blood products;Blood loss;Urine output;	—

Countries

China

Contacts

Public ContactWenfei Tan

The First Hospital of China Medical University

winfieldtan@hotmail.com+86 24 83283100

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026